<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tokyo_Tech_Experiment_Crosstalk_Circumvention_Assay"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tokyo Tech/Experiment/Crosstalk Circumvention Assay</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><DIV id="text-area"><DIV id="pagemenu"><UL id="dropmenu" class="qmmc"><LI><A class="qmparent2" href="https://2013.igem.org/Team:Tokyo_Tech">Home</A></LI><LI><A class="qmparent" href="javascript:void(0)">Project</A></LI><LI class="qmswitch"><A href="https://2013.igem.org/Team:Tokyo_Tech/Project/Ninja_State_Switching">Ninja State Switching</A></LI><LI class="qmm13"><A href="https://2013.igem.org/Team:Tokyo_Tech/Project/M13_Shuriken">M13 &quot;Shuriken&quot;</A></LI><LI class="qmfarming"><A href="https://2013.igem.org/Team:Tokyo_Tech/Project/Farming">Farming</A></LI></UL><LI><A class="qmparent" href="javascript:void(0)">Experiment</A></LI><LI class="qmswitch"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Confirmation_Assay">Crosstalk Confirmation Assay</A></LI><LI class="qmswitch"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay">Crosstalk Circumvention Assay</A></LI><LI class="qmm13"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/pSB-M13_Plasmid_Assay">pSB-M13 Plasmid Assay</A></LI><LI class="qmm13"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Inducible_Plaque_Forming_Assay">Inducible Plaque Forming Assay</A></LI><LI class="qmfarming"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/phoA_Promoter_Assay"><I>phoA</I> Promoter Assay</A></LI><LI class="qmfarming"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/Quantitative_Analysis_of_Cytokinin">Quantitative Analysis for Cytokinin</A></LI><LI class="qmfarming"><A href="https://2013.igem.org/Team:Tokyo_Tech/Experiment/RM-lac_Hybrid_Promoter_Assay"><I>RM/lac</I> Hybrid Promoter Assay</A></LI><LI><A class="qmparent" href="javascript:void(0)">Modeling</A></LI><LI class="qmswitch"><A href="https://2013.igem.org/Team:Tokyo_Tech/Modeling/Crosstalk_Circumvention">Crosstalk Circumvention</A></LI><LI class="qmfarming"><A href="https://2013.igem.org/Team:Tokyo_Tech/Modeling/Incoherent_Feed_Forward_Loop">Incoherent Feed Forward Loop</A></LI><LI><A class="qmparent2" href="https://2013.igem.org/Team:Tokyo_Tech/Submitted_Parts">Submitted Parts</A></LI><LI><A class="qmparent2" href="https://2013.igem.org/Team:Tokyo_Tech/Human_Practice">Human Practice</A></LI><LI><A class="qmparent" href="javascript:void(0)">More</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Attribution_and_Contribution">Attribution and Contribution</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Team">Team</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Collaboration">Collaboration</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Sponsors">Sponsors</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Origami">Origami</A></LI><LI><A href="https://igem.org/Team.cgi?id=1139">Official Team Profile</A></LI><LI><A href="https://2013.igem.org/Team:Tokyo_Tech/More/Judging_form">Judging form</A></LI><LI class="qmclear"> </LI></DIV></DIV><DIV id="text-area"><DIV class="box" id="title"><P style="line-height:0em; text-indent:0em;">Crosstalk Circumvention Assay</P></DIV><DIV class="box"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1"><A href="#1._Introduction"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">1. Introduction</SPAN></A></LI><LI class="toclevel-1"><A href="#2._Summary_of_the_experiment"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">2. Summary of the experiment</SPAN></A></LI><LI class="toclevel-1"><A href="#3._Prediction"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">3. Prediction</SPAN></A></LI><LI class="toclevel-1"><A href="#4._Materials_and_Methods"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext">4. Materials and Methods</SPAN></A></LI><LI class="toclevel-2"><A href="#4-1._Construction"><SPAN class="tocnumber">4.1</SPAN><SPAN class="toctext">4-1. Construction</SPAN></A></LI><LI class="toclevel-2"><A href="#4-2._Strain"><SPAN class="tocnumber">4.2</SPAN><SPAN class="toctext">4-2. Strain</SPAN></A></LI><LI class="toclevel-2"><A href="#4-3._Protocol"><SPAN class="tocnumber">4.3</SPAN><SPAN class="toctext">4-3. Protocol</SPAN></A></LI></UL><LI class="toclevel-1"><A href="#5._Results_of_the_assay"><SPAN class="tocnumber">5</SPAN><SPAN class="toctext">5. Results of the assay</SPAN></A></LI><LI class="toclevel-1"><A href="#6._Reference"><SPAN class="tocnumber">6</SPAN><SPAN class="toctext">6. Reference</SPAN></A></LI></TD></TR></TBODY></TABLE><H1><SPAN class="mw-headline" id="1._Introduction">1. Introduction </SPAN></H1><H2><P>Of course, if you want to avoid crosstalk, you have to search ideas for crosstalk circumvention.  However, you must make conditions without affecting system wide, or without changing the basis of system in the idea for improvement.  This is because &quot;crosstalk circumvention by changing system-wide&quot; is the same meaning as saying &quot;crosstalk circumvention only in that circuit&quot;.  For example, when you want to avoid crosstalk in the circuit on the basis of toggle switch system, you should think that it is nonsense to avoid crosstalk by abandoning toggle switch system.  You should think it's nice to avoid crosstalk without abandoning toggle switch system.  In short, I hope crosstalk circumvention system is applicable to various circuits.  Based on this view, we planned the following idea and experimentation.
</P></H2><H1><SPAN class="mw-headline" id="2._Summary_of_the_experiment">2. Summary of the experiment </SPAN></H1><H2><P>Our purpose is to check whether or not <I>lux/tet</I> hybrid promoter would be repressed when 3OC12HSL-LasR complex and protein TetR exist.  We tried to compare the frequency of crosstalk in the presence or absence of the aTc, the TetR inhibitor.
</P><P>We prepared six conditions as follow.
</P><BLOCKQUOTE><LI>E-1) Culture containing crosstalk circumvention system cell with 3OC6HSL induction
</LI><LI>E-2) Culture containing crosstalk circumvention system cell with 3OC12HSL induction
</LI><LI>E-3) Culture containing crosstalk circumvention system cell with DMSO (no induction)
</LI><LI>F-1) Culture containing crosstalk circumvention system cell with 3OC6HSL and aTc induction
</LI><LI>F-2) Culture containing crosstalk circumvention system cell with 3OC12HSL and aTc induction
</LI><LI>F-3) Culture containing crosstalk circumvention system cell with DMSO and aTc (no induction)
</LI><LI>Positive control and negative control are similarly operated.
</LI></BLOCKQUOTE><P>
 We also screened the concentration of 3OC6HSL and aTc, and examined activation of the crosstalk circumvention system circuit. Then we determined the transfer function of 3OC6HSL-LuxR complex by least squares method fitting and introduced into our <A href="https://2013.igem.org/Team:Tokyo_Tech/Modeling/Crosstalk_Circumvention#2-3._Parameter_optimization_and_simulation" class="external text" rel="nofollow">modeling</A>.
</P></H2><H1><SPAN class="mw-headline" id="3._Prediction">3. Prediction </SPAN></H1><H2><P>
aTc weakens the affinity of TetR for <I>tetO</I>.  Therefore, if the GFP expression level of the cells we added 3OC6HSL+aTc into was higher than that of the cells we added only 3OC6HSL into, it proved that <I>lux/tet</I> hybrid promoter is repressed by TetR.  Similarly, if the GFP expression level of the cells we added 3OC12HSL+aTc into was higher than that of the cells we added only 3OC12HSL into, it proved that the crosstalk can be suppressed by TetR and the hybrid promoter.
</P></H2><H1><SPAN class="mw-headline" id="4._Materials_and_Methods">4. Materials and Methods </SPAN></H1><H3><SPAN class="mw-headline" id="4-1._Construction">4-1. Construction </SPAN></H3><H2><P>
On the previous assay, we also confirmed crosstalk, which 3OC12HSL-LasR complex activates not only <I>las</I> promoter but also <I>lux</I> promoter (Gray KM et al., 1994).  We came up with an idea that crosstalk can be suppressed if <I>lux/tet</I> hybrid promoter is inhibited by protein TetR when 3OC12HSL-LasR complex exists.  We replaced <I>lux</I> promoter with <I>lux/tet</I> hybrid promoter.  What we have to do in this step is to confirm <I>lux/tet</I> hybrid promoter works correctly as a part of the system.  Therefore, we tried to make a simple crosstalk circumvention system (Fig. 3-2-1).  <I>luxR</I>, <I>tetR</I>, and <I>lasR</I> are under constitutive promoter.
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig. 3-2-1. Circuit of the simple crosstalk circumvention system</DIV></DIV></DIV></DIV><P>Because of the unexpected restriction enzyme binding site on the regulator plasmid, we had to place <I>luxR</I> and <I>tetR</I> on the regulator plasmid, and <I>lux/tet</I> hybrid promoter, <I>GFP</I> and <I>lasR</I> on the reporter plasmid (Fig. 3-2-2).
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig. 3-2-2. The actual circuit</DIV></DIV></DIV></DIV><P>
To construct the circuit in above figure (Fig. 3-2-2), we ligated Pcon-RBS-<I>lasR</I>-TT (<A href="http://parts.igem.org/Part:BBa_K553003" class="external text" rel="nofollow">BBa_K553003</A>) and Plux/tet-RBS-<I>GFP</I>-TT (<A href="http://parts.igem.org/Part:BBa_K934025" class="external text" rel="nofollow">BBa_K934025</A>) as the reporter plasmid. We used Pcon-RBS-<I>luxR</I>-TT-Ptrc-RBS-<I>tetR</I>-TT as the regulator plasmid.
</P><BLOCKQUOTE><LI>Reporter: pSB6A1-Pcon-<I>lasR</I>-Plux/tet-<I>GFP</I> / Regulator: pSB3K3-Pc-<I>luxR</I>-Ptrc-<I>tetR</I> (JM2.300)...sample</LI><LI>pSB6A1-Ptet-<I>GFP</I> (JM2.300)…positive control</LI><LI>pSB6A1-Promoterless-<I>GFP</I> (JM2.300)…negative control</LI></BLOCKQUOTE></H2><H3><SPAN class="mw-headline" id="4-2._Strain">4-2. Strain </SPAN></H3><H2>   JM2.300</H2><H3><SPAN class="mw-headline" id="4-3._Protocol">4-3. Protocol </SPAN></H3><H2>   1. O/N -&gt; FC -&gt; Induction<BLOCKQUOTE>1.1 Prepare overnight culture of each cell (GFP posi, GFP nega, sample) at 37°C for 12 h.  (=&gt; O/N)
</BLOCKQUOTE><BLOCKQUOTE>1.2 Take 30 µL (from GFP posi, GFP nega, sample) of the overnight culture of inducer cell into LB (3 mL) + antibiotics (Amp 50 µg/mL+ Kan 30 µg/mL).  (=&gt; Fresh Culture)
</BLOCKQUOTE><BLOCKQUOTE>1.3 Incubate the flesh culture of cells (GFP posi, GFP nega, sample) until the observed OD600 reaches around 0.50.
</BLOCKQUOTE><BLOCKQUOTE>1.4a Take 30 µL each cell suspensions (GFP posi , GFP nega , sample) into</BLOCKQUOTE><BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL) + 5 µM 3OC6HSL (3 µL),
</BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL) + 5 µM 3OC6HSL (3 µL) + 0.05 µg/mL aTc (3 µL),
</BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL) + 5 µM 3OC12HSL (3 µL),
</BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL+ Kan 30 µg/mL) + 5 µM 3OC12HSL (3 µL)+ 0.05 mg/mL aTc (3 µL),
</BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL) + 5 µM DMSO (3 µL),
</BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL) + 5 µM DMSO (3 µL) + 0.05 mg/mL aTc (3 µL).
</BLOCKQUOTE></BLOCKQUOTE><BLOCKQUOTE>1.4b Take 30 µL each cell suspensions (GFP posi , GFP 
     nega , sample) into
</BLOCKQUOTE><BLOCKQUOTE><BLOCKQUOTE>
LB (3 mL) + antibiotics (Amp 50 µg/mL + Kan 30 µg/mL)+ C6 (3 µL) + aTc (3 µL) … inducer concentration for each sample is shown in below (Fig 3-2-3)
</BLOCKQUOTE></BLOCKQUOTE><TABLE align="center" border="1"><TBODY><TR align="center"><TD colspan="7"><P>aTc (µg/mL)
</P></TD></TR><TR align="center"><TD rowspan="8" width="70"><P style="text-indent: 0em; padding-left: 0;">C6 (nM)</P></TD><TD width="60">0</TD><TD width="60">0.05</TD><TD width="60">0.15</TD><TD width="60">0.5</TD><TD width="60">1.5</TD><TD width="60">5</TD></TR><TR align="center"><TD>0</TD><TD>No. 1</TD><TD>No. 2</TD><TD>No. 3</TD><TD>No. 4</TD><TD>No. 5</TD><TD>No. 6</TD></TR><TR align="center"><TD>0.3</TD><TD>No. 7</TD><TD>No. 8</TD><TD>No. 9</TD><TD>No. 10</TD><TD>No. 11</TD><TD>No. 12</TD></TR><TR align="center"><TD>1</TD><TD>No. 13</TD><TD>No. 14</TD><TD>No. 15</TD><TD>No. 16</TD><TD>No. 17</TD><TD>No. 18</TD></TR><TR align="center"><TD>3</TD><TD>No. 19</TD><TD>No. 20</TD><TD>No. 21</TD><TD>No. 22</TD><TD>No. 23</TD><TD>No. 24</TD></TR><TR align="center"><TD>10</TD><TD>No. 25</TD><TD>No. 26</TD><TD>No. 27</TD><TD>No. 28</TD><TD>No. 29</TD><TD>No. 30</TD></TR><TR align="center"><TD>30</TD><TD>No. 31</TD><TD>No. 32</TD><TD>No. 33</TD><TD>No. 34</TD><TD>No. 35</TD><TD>No. 36</TD></TR><TR align="center"><TD>100</TD><TD>No. 37</TD><TD>No. 38</TD><TD>No. 39</TD><TD>No. 40</TD><TD>No. 41</TD><TD>No. 42</TD></TR></TBODY></TABLE><CENTER>Fig. 3-2-3. Inducer concentration for each sample</CENTER><BLOCKQUOTE>
1.5 Incubate all samples (6 samples X 6 kinds of culture = 36 samples) for another 4 h at 37°C.  (=&gt; Induction)
</BLOCKQUOTE></H2><H2>   2. Measurement (Flow cytometer)<P>2.1 Measure all samples' OD600.</P><P>2.2 Dilute all samples with 1X PBS to keep OD600 in the range from 0.2 to 0.5.
</P><P>2.3 Take 1 mL (from all samples) into disposable tube (for flow cytometer).
</P><P>2.4 Centrifuge them at 9,000g, 4°C, 1 min. and take their supernatant away.
</P><P>2.5 Suspend all samples with 1 mL 1X PBS.
</P><P>2.6 Measure all samples.
</P><P>2.7 Save and organize data.
</P></H2><H1><SPAN class="mw-headline" id="5._Results_of_the_assay">5. Results of the assay </SPAN></H1><H2><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig. 3-2-4. Crosstalk circumvention results</DIV></DIV></DIV></DIV></H2><H2><P>Fig. 3-2-4 shows the following.  <I>lux/tet</I> hybrid promoter is repressed by TetR in the presence of 3OC6HSL-LuxR complex.  Similarly, <I>lux/tet</I> hybrid promoter is repressed by TetR in the presence of 3OC12HSL-LasR complex.  In brief, results from E-1) and F-1) are similar to those from E-2) and F-2).  Therefore, the crosstalk circumvention experiment succeeded.
</P></H2><H2><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:502px;"><DIV class="thumbcaption">Fig. 3-2-5. Activation of the crosstalk circumvention system circuit</DIV></DIV></DIV></DIV></H2><H2><P>Fig. 3-2-5 shows activation of the crosstalk circumvention system circuit. It shows transition of the fluorescence intensity of GFP. It indicates that the concentration of C6 saturates between 10 mM and 30 mM.
</P></H2><H1><SPAN class="mw-headline" id="6._Reference">6. Reference </SPAN></H1><H2><OL><LI>
Gray KM, Passador L (1994) Interchangeability and specificity of components from the quorum-sensing regulatory systems of Vibrio fischeri and Pseudomonas aeruginosa.  Journal of bacteriology 176(10): 3076–3080.</LI></OL></H2></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay">http://2013.igem.org/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tokyo_Tech/Experiment/Crosstalk_Circumvention_Assay&amp;oldid=360012" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>